Ancient human relative cannibalized both adults and children in a cave in Spain 850,000 years ago, fossils revealJuly 27, 2026
Research First-in-Class Drug for ADHD Wins FDA ApprovalBy Healthcare Propulsion StaffJuly 27, 20260 The FDA approved oral centanafadine (Simtriyo), a first-in-class triple reuptake inhibitor for attention deficit-hyperactivity disorder (ADHD), Otsuka announced late last…
